117 related articles for article (PubMed ID: 36161669)
1. Imaging of the calcium activated potassium channel 3.1 (K
Konken CP; Heßling K; Thale I; Schelhaas S; Dabel J; Maskri S; Bulk E; Budde T; Koch O; Schwab A; Schäfers M; Wünsch B
Arch Pharm (Weinheim); 2022 Dec; 355(12):e2200388. PubMed ID: 36161669
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K
Brömmel K; Konken CP; Börgel F; Obeng-Darko H; Schelhaas S; Bulk E; Budde T; Schwab A; Schäfers M; Wünsch B
RSC Adv; 2021 Sep; 11(48):30295-30304. PubMed ID: 35480282
[TBL] [Abstract][Full Text] [Related]
3. Imaging of K
Thale I; Maskri S; Grey L; Todesca LM; Budde T; Maisuls I; Strassert CA; Koch O; Schwab A; Wünsch B
ChemMedChem; 2023 Jan; 18(2):e202200551. PubMed ID: 36315933
[TBL] [Abstract][Full Text] [Related]
4. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
5. Co-staining of K
Brömmel K; Maskri S; Bulk E; Pethő Z; Rieke M; Budde T; Koch O; Schwab A; Wünsch B
ChemMedChem; 2020 Dec; 15(24):2462-2469. PubMed ID: 33043595
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Small-Molecule Fluorescent Probes for the In Vitro Imaging of Calcium-Activated Potassium Channel K
Brömmel K; Maskri S; Maisuls I; Konken CP; Rieke M; Pethő Z; Strassert CA; Koch O; Schwab A; Wünsch B
Angew Chem Int Ed Engl; 2020 May; 59(21):8277-8284. PubMed ID: 32097518
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
10. High-Contrast CXCR4-Targeted
Kwon D; Lozada J; Zhang Z; Zeisler J; Poon R; Zhang C; Roxin Á; Lin KS; Perrin D; Benard F
Mol Pharm; 2021 Jan; 18(1):187-197. PubMed ID: 33253591
[TBL] [Abstract][Full Text] [Related]
11. Radiosynthesis and Biological Evaluation of [
Litchfield M; Wuest M; Glubrecht D; Wuest F
Mol Pharm; 2020 Jan; 17(1):251-261. PubMed ID: 31816246
[TBL] [Abstract][Full Text] [Related]
12. A Metal-Free DOTA-Conjugated
Roxin Á; Zhang C; Huh S; Lepage M; Zhang Z; Lin KS; Bénard F; Perrin DM
Bioconjug Chem; 2019 Apr; 30(4):1210-1219. PubMed ID: 30896929
[TBL] [Abstract][Full Text] [Related]
13. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
[TBL] [Abstract][Full Text] [Related]
14. One-step
Zhao X; Lv G; Li K; Peng Y; Liu Q; Qiu L; Lin J
Nucl Med Biol; 2020; 82-83():72-79. PubMed ID: 32109829
[TBL] [Abstract][Full Text] [Related]
15. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
16. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
18. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
[TBL] [Abstract][Full Text] [Related]
19.
Lamichhane N; Dewkar GK; Sundaresan G; Wang L; Jose P; Otabashi M; Morelle JL; Farrell N; Zweit J
J Nucl Med; 2017 Dec; 58(12):1997-2003. PubMed ID: 28729428
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.
Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL
Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]